168 related articles for article (PubMed ID: 33789152)
1. Levels of anti-B13 antibodies over time in a cohort of chronic infected by Trypanosoma cruzi. Its relationship with specific treatment and clinical status.
Olivera V; Bizai ML; Arias E; Suasnabar S; Bottasso O; Marcipar I; Fabbro D
Acta Trop; 2021 Jun; 218():105908. PubMed ID: 33789152
[TBL] [Abstract][Full Text] [Related]
2. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
[TBL] [Abstract][Full Text] [Related]
3. Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina.
Niborski LL; Grippo V; Lafón SO; Levitus G; García-Bournissen F; Ramirez JC; Burgos JM; Bisio M; Juiz NA; Ayala V; Coppede M; Herrera V; López C; Contreras A; Gómez KA; Elean JC; Mujica HD; Schijman AG; Levin MJ; Longhi SA
Mem Inst Oswaldo Cruz; 2016 May; 111(6):365-71. PubMed ID: 27223650
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the ELISA-F29 test as an early marker of therapeutic efficacy in adults with chronic Chagas disease.
Fabbro D; Velazquez E; Bizai ML; Denner S; Olivera V; Arias E; Pravia C; Ruiz AM
Rev Inst Med Trop Sao Paulo; 2013; 55(3):. PubMed ID: 23740013
[TBL] [Abstract][Full Text] [Related]
5. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
[TBL] [Abstract][Full Text] [Related]
6. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease.
Gazzinelli RT; Galvao LM; Krautz G; Lima PC; Cancado JR; Scharfstein J; Krettli AU
Am J Trop Med Hyg; 1993 Nov; 49(5):625-35. PubMed ID: 8250103
[TBL] [Abstract][Full Text] [Related]
7. Assessing antibody decline after chemotherapy of early chronic Chagas disease patients.
Murphy N; Cardinal MV; Bhattacharyya T; Enriquez GF; Macchiaverna NP; Alvedro A; Freilij H; Martinez de Salazar P; Molina I; Mertens P; Gilleman Q; Gürtler RE; Miles MA
Parasit Vectors; 2021 Oct; 14(1):543. PubMed ID: 34670602
[TBL] [Abstract][Full Text] [Related]
8. Use of a recombinant Trypanosoma cruzi protein antigen to monitor cure of Chagas disease.
Guevara AG; Taibi A; Alava J; Guderian RH; Ouaissi A
Trans R Soc Trop Med Hyg; 1995; 89(4):447-8. PubMed ID: 7570896
[No Abstract] [Full Text] [Related]
9. Trypanocidal therapy among children infected by Trypanosoma cruzi. Serological and electrocardiographic changes over a mean twenty-five-years follow-up period.
Suasnábar S; Olivera LV; Arias E; Bizai ML; Bottasso O; Arias E; Fabbro D
Acta Trop; 2021 Oct; 222():106050. PubMed ID: 34302770
[TBL] [Abstract][Full Text] [Related]
10. Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up study.
Galvao LM; Nunes RM; Cançado JR; Brener Z; Krettli AU
Trans R Soc Trop Med Hyg; 1993; 87(2):220-3. PubMed ID: 8337734
[TBL] [Abstract][Full Text] [Related]
11. Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission.
Sosa-Estani S; Cura E; Velazquez E; Yampotis C; Segura EL
Rev Soc Bras Med Trop; 2009; 42(5):484-7. PubMed ID: 19967227
[TBL] [Abstract][Full Text] [Related]
12. Quantification of Immunoglobulin G against Trypanosoma cruzi in Individuals with Chronic Chagas Disease Treated with Nifurtimox and Evaluated in Prolonged Follow-Up.
Muñoz G; Vergara C; Martínez G; Apt W; Zulantay I
Korean J Parasitol; 2019 Feb; 57(1):39-41. PubMed ID: 30840798
[TBL] [Abstract][Full Text] [Related]
13. Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives.
Lauria-Pires L; Braga MS; Vexenat AC; Nitz N; Simões-Barbosa A; Tinoco DL; Teixeira AR
Am J Trop Med Hyg; 2000; 63(3-4):111-8. PubMed ID: 11388500
[TBL] [Abstract][Full Text] [Related]
14. Humoral immune response against P2β from Trypanosoma cruzi in persons with chronic Chagas disease: its relationship with treatment against parasites and myocardial damage.
Fabbro DL; Olivera V; Bizai ML; Denner S; Diez C; Marcipar I; Streiger M; Arias E; del Barco M; Mendicino D; Bottasso O
Am J Trop Med Hyg; 2011 Apr; 84(4):575-80. PubMed ID: 21460013
[TBL] [Abstract][Full Text] [Related]
15. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient.
Cunha-Neto E; Coelho V; Guilherme L; Fiorelli A; Stolf N; Kalil J
J Clin Invest; 1996 Oct; 98(8):1709-12. PubMed ID: 8878420
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen.
Cunha-Neto E; Duranti M; Gruber A; Zingales B; De Messias I; Stolf N; Bellotti G; Patarroyo ME; Pilleggi F; Kalil J
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3541-5. PubMed ID: 7536937
[TBL] [Abstract][Full Text] [Related]
17. Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas.
Fabbro DL; Danesi E; Olivera V; Codebó MO; Denner S; Heredia C; Streiger M; Sosa-Estani S
PLoS Negl Trop Dis; 2014 Nov; 8(11):e3312. PubMed ID: 25411847
[TBL] [Abstract][Full Text] [Related]
18. Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole.
Chippaux JP; Clavijo AN; Santalla JA; Postigo JR; Schneider D; Brutus L
Trop Med Int Health; 2010 Jan; 15(1):87-93. PubMed ID: 19968839
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cross-reactive host-pathogen antibodies in patients with different stages of chronic Chagas disease.
Vicco MH; Ferini F; Rodeles L; Cardona P; Bontempi I; Lioi S; Beloscar J; Nara T; Marcipar I; Bottasso OA
Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):791-6. PubMed ID: 24773859
[TBL] [Abstract][Full Text] [Related]
20. Reversibility of muscle and heart lesions in chronic, Trypanosoma cruzi infected mice after late trypanomicidal treatment.
Segura MA; Molina de Raspi E; Basombrio MA
Mem Inst Oswaldo Cruz; 1994; 89(2):213-6. PubMed ID: 7885247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
